Search

Your search keyword '"Ait Ali, H"' showing total 13 results
Start Over Author "Ait Ali, H"
13 results on '"Ait Ali, H"'

1. Epidemiological Study on β-Thalassemia in Algeria

Author

Grifi, Fatiha, primary, Djenouni, A, additional, Bougherira, S, additional, Abad, MT, additional, Boucherit, C, additional, Boudjerra, N, additional, Zidani, N, additional, Aboura, C, additional, Aribi, A, additional, Belhani, M, additional, Nekkal, S, additional, Bouaricha, H, additional, Benhassine, Fz, additional, Ahmed Nacer, R, additional, Tensaout, F, additional, Ait amer, N, additional, Hamladji, RM, additional, Hamdi, S, additional, Zatout, S, additional, Sidi Mansour, N, additional, Ouchenane, Z, additional, Belakehal, SE, additional, Mansour, H, additional, Ghassoul, Y, additional, Djilali, M, additional, Ardjoun, Fz, additional, Lakhdari, N, additional, Touati, L, additional, Bouterfa, N, additional, Fenghour, R, additional, Ait Ali, H, additional, Graine, A, additional, Allouda, M, additional, Bouacha, A, additional, Saidi, D, additional, Sfaoui, W, additional, Touhami, H, additional, Bouchair, N, additional, Hamani, N, additional, Saidi, M, additional, Nacib, R, additional, Bekache, A, additional, Dridi, R, additional, Mesli, N, additional, Houti, N, additional, Ouarlhent, Y, additional, Chichoune, S, additional, Mehalhal, N, additional, Zouaoui, Z, additional, Benallal, A, additional, Bekadja, MA, additional, and Benakli, Malek, additional

Published
2018
Full Text
View/download PDF

2. Epidemiological Study of Aplastic Anemia in Algeria for 844 Cases over 10 Years (2007-2016)

Author

Mehdid, F, primary, Rekkab, N, additional, Oukid, S, additional, Abad, MT, additional, Bradai, M, additional, Hamdi, S, additional, Boukhemia, F, additional, Hamladji, RM, additional, Ahmed Nacer, R, additional, Allouda, M, additional, Ait Ali, H, additional, Benaichou, S, additional, Zouaoui, Z, additional, Boughrira, S, additional, Grifi, F, additional, Cherif, N, additional, Bensenouci, A, additional, Kaci, Z, additional, Belhani, M, additional, Boudjerra, N, additional, Serradj, F, additional, Bekadja, MA, additional, Kehal, M, additional, Touhami, H, additional, Saidi, D, additional, Gareh, B, additional, Saidi, M, additional, Sahraoui, L, additional, Ardjoun, Fz, additional, Belakehal, SE, additional, Chichoune, S, additional, Ouarlhent, Y, additional, Bendahmane, F, additional, Mesli, N, additional, Benhalilou, M, additional, Sidi Mansour, N, additional, Benmoufek, N, additional, Ladj, S, additional, Hadji, W, additional, Bensmaine, N, additional, Hendel, N, additional, Arbaoui, F, additional, Mehalhal, N, additional, Hadji, S, additional, Bachiri, A, additional, Touati, L, additional, Lakhdari, N, additional, Ferroudj, N, additional, Nekkal, S, additional, Boudiaf, H, additional, Achir, M, additional, Fafa, A, additional, and Benakli, Malek, additional

Published
2018
Full Text
View/download PDF

3. Epidemiology of Extranodal Diffuse Large B Cell Lymphomas in Algeria: A Study of the Algerian Group of Extranodal Lymphomas (GALEG)

Author

Hamdi, S, primary, Bentahar, I, additional, Harbadji, H, additional, Grifi, F, additional, Bougherira, S, additional, Filali, T, additional, Smaili, F, additional, Djabellah, A, additional, Ait Ali, H, additional, Allouda, M, additional, Mesli, N, additional, Berber, B, additional, Bouzid, K, additional, Sai, R, additional, Hamladji, RM, additional, Ahmed Nacer, R, additional, Ait Ameur, N, additional, Belhadri, F, additional, Bekadja, MA, additional, Charef, L, additional, Touhami, H, additional, Zatla, L, additional, Belhani, M, additional, Boudjerra, N, additional, Nekkal, S, additional, Louanchi, L, additional, Saidi, M, additional, Bougoufa, S, additional, Bitam, M, additional, Mehalhal, N, additional, Abad, MT, additional, Oukid, S, additional, Ardjoun, Fz, additional, Belakehal, SE, additional, Sahraoui, L, additional, Oukal, M, additional, Zouaoui, Z, additional, Si Ali, N, additional, Bachiri, A, additional, Belkesmaoui, L, additional, Bendjabellah, B, additional, Lamara, D, additional, Lakhdari, N, additional, Touati, L, additional, Sidi Mansour, N, additional, Ouarhlent, Y, additional, Bouaoud, S, additional, Kara, L, additional, and Benakli, M, additional

Published
2016
Full Text
View/download PDF

4. Descriptive Study of Diffuse Large B Cell Lymphoma in Algeria and Tunisia over a Period of 5 Years

Author

Boudjerra, N, primary, Oukid, S, additional, Abad, MT, additional, Aboura, C, additional, Louanchi, L, additional, Ramaoun, M, additional, Belhani, M, additional, Allouda, M, additional, Aftisse, H, additional, Ait Ali, H, additional, Ben lakhal, R, additional, Meddeb, B, additional, Ait Ameur, N, additional, Belhadri, F, additional, Tensaout, F, additional, Ahmed Nacer, R, additional, Hamladji, RM, additional, Bougherira, S, additional, Grifi, F, additional, Ghassouli, Y, additional, Djilali, M, additional, Belakehal, SE, additional, Ardjoun, Fz, additional, Bouchama, S, additional, Charef, L, additional, Bekadja, MA, additional, Benhalilou, M, additional, Sidi Mansour, N, additional, Kechichi, A, additional, Hamdi, S, additional, Bellaaj, H, additional, Berber, B, additional, Mesli, N, additional, Zatla, L, additional, Touhami, H, additional, Laatiri, MA, additional, Si Ali, N, additional, Zouaoui, Z, additional, Hamza, H, additional, Ouarhlent, Y, additional, Belkesmaoui, N, additional, Ghedira, H, additional, Khemiri, M, additional, Mehalhal, N, additional, Lakhdari, N, additional, Saidi, M, additional, Behloul, S, additional, Lazzazi, A, additional, Abrouk, S, additional, Ben Othman, T, additional, and Benakli, M, additional

Published
2016
Full Text
View/download PDF

5. Evaluation of the Imatinib Treatment of Patients with Chronic Myeloid Leukemia (CML). a Retrospective Study from Algerian Working Group on CML (GAT-LMC)

Author

Djouadi, K, primary, Bouchakour, A, additional, Taoussi, S, additional, Abad, MT, additional, Ouchenane, Z, additional, Sidi Mansour, N, additional, Abdennebi, N, additional, Harieche, F, additional, Ahmed Nacer, R, additional, Hamladji, RM, additional, Touil, Fz, additional, Hamdi, S, additional, Entasoltane, B, additional, Brahimi, M, additional, Nachi, M, additional, Bekadja, MA, additional, Kerrar, C, additional, Allam, L, additional, Djidjik, O, additional, Boudjerra, N, additional, Belhani, M, additional, Bougherira, S, additional, Grifi, F, additional, Gherras, S, additional, Graine, A, additional, Ait Ali, H, additional, Brahimi, Z, additional, Touati, L, additional, Lakhdari, N, additional, Mehalhal, N, additional, Taibi, K, additional, Touhami, H, additional, Benzineb, B, additional, Mesli, N, additional, Saber Cherif, D, additional, Rahali, C, additional, Mansour, N, additional, Meddour, Y, additional, Chaib, S, additional, Ardjoun, Fz, additional, Maghraoui, F, additional, Hadjeb, S, additional, Zenori, M, additional, Benlazhar, M, additional, Zouaoui, Z, additional, Baghdad, S, additional, Bachiri, A, additional, Lamara, D, additional, Bendjabellah, B, additional, and Benakli, M, additional

Published
2016
Full Text
View/download PDF

6. Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study

Author

Djouadi, K, primary, Abdennebi, N, additional, Harieche, F, additional, Ahmed Nacer, R, additional, Hamladji, RM, additional, Bouchakour, A, additional, Taoussi, S, additional, Abad, MT, additional, Touil, Fz, additional, Hamdi, S, additional, Bougherira, S, additional, Grifi, F, additional, Kerrar, C, additional, Allam, I, additional, Djidjik, O, additional, Boudjerra, N, additional, Belhani, M, additional, Gherras, S, additional, Graine, A, additional, Ait Ali, H, additional, Entasoltane, B, additional, Brahimi, M, additional, Bekadja, MA, additional, Ben lakhal, R, additional, Meddeb, B, additional, Ouchenane, Z, additional, Sidi Mansour, N, additional, Kacha, F, additional, Tibermacine, F, additional, Saidi, M, additional, Mehalhal, N, additional, Brahimi, Fz, additional, Touati, L, additional, Lakhdari, N, additional, Saber Cherif, D, additional, Meddour, Y, additional, Chaib, S, additional, Ardjoun, Fz, additional, Bellaaj, H, additional, Taibi, K, additional, Touhami, H, additional, Manai, HZ, additional, Benzineb, B, additional, Mesli, N, additional, Maghraoui, A, additional, Hadjeb, S, additional, Zouaoui, Z, additional, Baghdad, S, additional, Bachiri, A, additional, Laatiri, MA, additional, Attari, M, additional, Lamara, D, additional, Bendjabellah, B, additional, Ghedira, H, additional, Ben Youcef, Y, additional, Trabzi, A, additional, Menif, S, additional, Ben Othman, T, additional, and Benakli, M, additional

Published
2016
Full Text
View/download PDF

7. Epidemiology and Clinical Features of Adults Myelodysplastic Syndromes in Algeria: A Population-Based Study. Review of the Algerian Myelodysplastic Syndromes Study Group

Author

Bekadja, MA, primary, Ahmed Nacer, R, additional, Hamladji, RM, additional, Boudjerra, N, additional, Belhani, M, additional, Ardjoun, Fz, additional, Abad, MT, additional, Touhami, H, additional, Ait Ali, H, additional, Zouaoui, Z, additional, Sidi Mansour, N, additional, Hamdi, S, additional, Grifi, F, additional, Mesli, N, additional, Saidi, M, additional, Lakhdari, N, additional, Mehalhal, N, additional, Bachiri, A, additional, Bendjabellah, B, additional, Nekkal, S, additional, Osmani, S, additional, Kaci, Z, additional, Taoussi, S, additional, Zouani, S, additional, Graine, A, additional, Benlazhar, M, additional, Bouabellah, S, additional, Benzineb, B, additional, Belkhodja, Fz, additional, Bougherira, S, additional, Aiche, M, additional, Aberkane, M, additional, Touati, L, additional, and Benakli, M, additional

Published
2015
Full Text
View/download PDF

8. Epidemiology and Clinical Features of Chronic Lymphoid Leukemia. Review of the Algerian Chronic Lymphoid Leukemia Study Group

Author

Dali, N, primary, Ait Ali, H, additional, Tibiche, A, additional, Belhadri, F, additional, Harieche, F, additional, Ahmed Nacer, R, additional, Hamladji, RM, additional, Taoussi, S, additional, Oukid, S, additional, Abad, MT, additional, Kerrar, C, additional, Boudjerra, N, additional, Belhani, M, additional, Bougherira, S, additional, Grifi, F, additional, Saidi, D, additional, Touhami, H, additional, Mahdad, S, additional, Bekadja, MA, additional, Bouhedda, Z, additional, Hamdi, S, additional, Ould Kablia, N, additional, Ardjoun, Fz, additional, Ouaddah, F, additional, Zouaoui, Z, additional, Bougofa, S, additional, Saidi, M, additional, Benhalilou, M, additional, Sidi Mansour, N, additional, Khiat, R, additional, Mesli, N, additional, Mehalhal, N, additional, Brahimi, Z, additional, Lakhdari, N, additional, Bendjabellah, B, additional, Bachiri, A, additional, and Benakli, M, additional

Published
2015
Full Text
View/download PDF

9. Epidemiological Data from the Algerian Multiple Myeloma Registry (AMMR) over 2 Years (June 2014-June 2016): Report of the Algerian Multiple Myeloma Study Group (GETMA)

Author

Saidi, M, Abad, MT, Taoussi, S, Ghezlane, C, Hamladji, RM, Ahmed Nacer, R, Belhadri, F, Moussaoui, H, Ait Ali, H, Aftisse, H, Ardjoun, Fz, Belakehal, SE, Rahali, C, Belhani, M, Boudjerra, N, Berkouk, Y, Ramaoun, M, Ahmidatou, H, Bekadja, MA, Talhi, S, Ouldjeriouat, H, Grifi, F, Boughrira, S, Smaili, K, Mesli, N, Bendahmane, F, Hamdi, S, Belkhodja, Fz, Amoura, A, Menia, H, Rechache, H, Zouaoui, Z, El mestari, A, Touhami, H, Mrabet, R, Lakhdari, N, Brahimi, Z, Zeghouati, S, Sidi Mansour, N, Benhalilou, M, Mehalhal, N, Bendjabellah, B, Chehili, W, Bachiri, A, Abderahmani, S, Ouarhlent, Y, Zidani, H, Nekkal, S, Bouchakor, Y, Hamouda, H, Mehdid, F, Saidi, D, Baichi, F, and Benakli, M

Published
2017
Full Text
View/download PDF

10. Epidemiological Study on ß-Thalassemia in Algeria

Author

Grifi, Fatiha, Djenouni, A, Bougherira, S, Abad, MT, Boucherit, C, Boudjerra, N, Zidani, N, Aboura, C, Aribi, A, Belhani, M, Nekkal, S, Bouaricha, H, Benhassine, Fz, Ahmed Nacer, R, Tensaout, F, Ait amer, N, Hamladji, RM, Hamdi, S, Zatout, S, Sidi Mansour, N, Ouchenane, Z, Belakehal, SE, Mansour, H, Ghassoul, Y, Djilali, M, Ardjoun, Fz, Lakhdari, N, Touati, L, Bouterfa, N, Fenghour, R, Ait Ali, H, Graine, A, Allouda, M, Bouacha, A, Saidi, D, Sfaoui, W, Touhami, H, Bouchair, N, Hamani, N, Saidi, M, Nacib, R, Bekache, A, Dridi, R, Mesli, N, Houti, N, Ouarlhent, Y, Chichoune, S, Mehalhal, N, Zouaoui, Z, Benallal, A, Bekadja, MA, and Benakli, Malek

Abstract

No relevant conflicts of interest to declare.

Published
2018
Full Text
View/download PDF

11. Solitary and complicated neurofibroma of small Bowel: A case report.

Author

Ait Ali H, Zeriouh B, Egyir Ebo U, Serji B, and Elharroudi T

Abstract

Introduction: Neurofibromatosis is a genetic disorder characterized by tumors and pigmentary changes on the skin, such as spots that color leans to 'White Coffee'. Neurofibromas of the gastrointestinal tract are commonly associated with neurofibromatosis type I (NF1). Although, digestive involvement can be the single manifestation of the disease and may consequently; represent the only diagnostic element., Presentation of Case: We report here; a case of a patient admitted to the emergency department with a bowel obstruction, for which radiological investigations revealed the presence of intussusception due to an intestinal tumor. The patient underwent a bowel resection with anastomosis, and then, after being examined histologically, the result has identified an intestinal neurofibroma without evidence of malignancy. Then and on the fourth day following the surgery, the patient was discharged with good clinical improvement., Discussion: The intestinal neurofibroma may be the first and the only manifestation of neurofibromatosis type I. Also, it's uncommon to present a neurofibroma isolated from the small bowel with an intussusception, which makes the pre-surgical diagnosis very difficult. And until now, only a few case reports of these conditions have been reported., Conclusion: We report this uncommon clinical case of an isolated neurofibroma from the small bowel to raise awareness among the medical team about this exceptional pathology. Nevertheless, its risk of developing serious complications and malignant transformation led us to opt for earlier surgical treatment. Furthermore, it requires a close clinical follow-up to eliminate the neurofibromatosis type I or the multiple endocrine neoplasia type II., (Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.)

Published
2021
Full Text
View/download PDF

12. Sigmoid Colon Tuberculosis Revealed by a Perforation and Peritonitis.

Author

Ait Ali H, Zeriouh B, Jabi R, and Bouziane M

Abstract

Intestinal tuberculosis is a frequent disease in developing countries, causing considerable morbidity and mortality. However, tuberculosis of the colon is rarer, and it also appears to be more common in immunosuppressed patients. We report the case of a 71-year-old immunocompetent man who was admitted to the emergency department with an acute abdomen and features of perforation peritonitis. A sigmoid perforation on cancer was suspected on computed tomography (CT) scan and surgical exploration. A standard sigmoidectomy with end colostomy (Hartmann's procedure) and peritoneal toileting was done. The pathological assessment of the surgical specimen revealed the sigmoid colon tuberculosis, complicated by perforation and peritonitis. Thus, the unexpected diagnosis of sigmoid colon tuberculosis was only made after the histopathological examination. Then, he received anti-tuberculosis treatment for six months. Therefore, a complete colonoscopy was performed at the end of the treatment, which returned to be normal. Thereafter, the restoration of intestinal continuity was performed. Colon tuberculosis is a rare disease and even rarer in people without immunodeficiency or on immunosuppressive therapy. If diverticulitis is the most common cause of sigmoid perforation, sigmoid perforation because of tuberculosis is extremely rare. However, an isolated primary sigmoid perforation of tubercular origin is not reported. We report this exceptional case of sigmoid colon tuberculosis complicated by perforation and generalized peritonitis to sensitize the medical team to its rare occurrence, which will be of paramount importance due to the increasing incidence of tuberculosis worldwide., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2020, Ait Ali et al.)

Published
2020
Full Text
View/download PDF

13. A population-based study of the epidemiology and clinical features of adults with acute myeloid leukemia in Algeria: report on behalf of the Algerian Acute Leukemia Study Group.

Author

Bekadja MA, Hamladji RM, Belhani M, Ardjoun FZ, Abad MT, Touhami H, Ait-Ali H, Zouaoui Z, Sidimansour N, Hamdi S, Grifi F, Mesli N, Saidi M, Mehalhal N, Bachiri A, Bouhass R, Said YM, and Midoun N

Subjects
Adolescent, Adult, Aged, Aged, 80 and over, Algeria epidemiology, Female, Humans, Incidence, Leukemia, Myeloid, Acute diagnosis, Male, Middle Aged, Retrospective Studies, Young Adult, Leukemia, Myeloid, Acute epidemiology
Abstract

Background and Objectives: In Algeria, the incidence of hematologic malignancies has been difficult to estimate for many years. Today, many hematological centers, including 14 university hospitals, have been developed in the entire north and have useful epidemiological data pertinent to acute myeloid leukemia (AML). We studied the incidence of AML and its subtypes, age distribution, geographic distribution and trends in the rate of diagnosis over the last 5 years in Algeria. Secondary goals were to study trends of referral of AML cases from various regions to specific centers to assess the needs for health infrastructure and change of current practices., Design and Setting: Retrospective analysis of nationwide survey of all adult cases of AML (>16 years) diagnosed between 1 January 2006 and 31 December 2010., Patients and Methods: A survey form was distributed to all departments of hematology at the 15 participating centers., Results: The 1426 cases of AML diagnosed during the study period represented an annual incidence of 0.91/100000 persons with a male to female (M/F) ratio of 1:16 and a median age of 45 years (range, 16-82 years). Nationally, 20% of cases AML were diagnosed in the whole western region of the country, 47% in the central and 33% in the east. There was a trend of continuous increase in the rate with age and in the rate of diagnosis over the last 5 years. The most common subtype was M2, followed by M4 and M5., Conclusion: An overall increase in the number of AML patients diagnosed nationwide over the last five years indicates a need for additional health care resources including curative and therapy-intense strategies, such as stem cell transplant facilities to optimize outcome. The relatively younger age of patients compared to the Western countries may be due to the demographic composition of our population.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results